Business Context and Reporting Period
This Form 8-K reports on the Annual Meeting of Shareholders held by BioRestorative Therapies, Inc. on December 7, 2012. The filing details the voting results for the election of directors and several corporate governance proposals.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on shareholder voting outcomes and corporate actions.
Material Changes and Voting Results
All matters presented at the Annual Meeting were approved, and all director nominees were elected. Key voting outcomes include:
- Election of Directors: Mark Weinreb, A. Jeffrey Radov, and Joel San Antonio were elected. Approximately 455.6 million shares voted "For" each nominee, with roughly 26 million shares withheld and 66.2 million broker non-votes.
- Equity Plan Amendment: Shareholders approved increasing the authorized shares under the 2010 Equity Participation Plan from 200,000,000 to 300,000,000. Votes were 454.1 million "For" versus 26.3 million "Against."
- Reverse Stock Split Extension: Shareholders approved extending the Board's authority to effect a reverse stock split (ratio between 1-for-10 and 1-for-150) by one year. Votes were 515.9 million "For" versus 29.3 million "Against."
- Authorized Shares Reduction: Shareholders authorized the Board to reduce the number of authorized common stock shares proportionally if a reverse split is executed. Votes were 518.3 million "For" versus 26.8 million "Against."
- Adjournment Authority: Shareholders authorized the adjournment of the meeting to solicit further proxies if necessary. Votes were 515.0 million "For" versus 6.7 million "Against."
Guidance, Outlook, and Risks
The filing does not contain management commentary, financial guidance, or specific risk factors. The primary corporate action noted is the Board's retained discretion to execute a reverse stock split within the approved parameters (1-for-10 to 1-for-150) and to adjust authorized share counts accordingly.
Investor Verification Checklist
- Verify the current status of the reverse stock split authorization and whether the Board has elected to execute it.
- Confirm the updated number of authorized shares under the 2010 Equity Participation Plan (now 300,000,000).
- Review subsequent filings to determine if the adjournment authority was utilized or if the reverse split was implemented.
- Check the latest 10-K or 10-Q for financial performance data, as this 8-K contains no financial metrics.